{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:12:09Z","timestamp":1793391129151,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374102"],"award-info":[{"award-number":["82374102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2022RCZXZK32"],"award-info":[{"award-number":["2022RCZXZK32"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.phymed.2024.155776","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T17:13:30Z","timestamp":1716570810000},"page":"155776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway"],"prefix":"10.1016","volume":"131","author":[{"given":"Lulu","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-0823","authenticated-orcid":false,"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-4164","authenticated-orcid":false,"given":"Yuwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155776_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117978","article-title":"Liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed mice","volume":"256","author":"Ai","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2024.155776_bib0012","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10571-022-01250-3","article-title":"Role of pyroptosis, a Pro-inflammatory programmed cell death, in epilepsy","volume":"43","author":"Atabaki","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phymed.2024.155776_bib0026","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/00033197221091317","article-title":"Atherosclerosis and non-alcoholic fatty liver disease","volume":"73","author":"Balta","year":"2022","journal-title":"Angiology"},{"key":"10.1016\/j.phymed.2024.155776_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877924","article-title":"Protective effect of Danshen Zexie decoction against non-alcoholic fatty liver disease through inhibition of ROS\/NLRP3\/IL-1beta Pathway by Nrf2 signaling activation","volume":"13","author":"Biao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0027","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2024.155776_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.858795","article-title":"Multi-Omics integration analysis identifies lipid disorder of a non-alcoholic fatty liver disease (NAFLD) mouse model improved by Zexie-Baizhu decoction","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175670","article-title":"Hesperidin may improve depressive symptoms by binding NLRP3 and influencing the pyroptosis pathway in a rat model","volume":"952","author":"Cao","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0029","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FJC.0000000000000079","article-title":"Molecular analysis of curcumin-induced polarization of murine RAW264.7 macrophages","volume":"63","author":"Chen","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0028","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/cr.2016.100","article-title":"Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.phymed.2024.155776_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.actbio.2023.08.009","article-title":"Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1alpha","volume":"169","author":"Cui","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phymed.2024.155776_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1113883","article-title":"Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages","volume":"14","author":"Drummer","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2024.155776_bib0036","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2024.155776_bib0001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.155776_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109408","article-title":"Through regulation of the SIRT1 pathway plant sterol ester of alpha-linolenic acid inhibits pyroptosis thereby attenuating the development of NASH in mice","volume":"119","author":"Han","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phymed.2024.155776_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.intimp.2019.01.002","article-title":"Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis","volume":"68","author":"Hua","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115246","article-title":"Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K\/Akt\/mTOR signaling pathway","volume":"293","author":"Jin","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0013","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41419-023-06221-0","article-title":"SIRT1 regulates hepatocyte programmed cell death via GSDME - IL18 axis in human and mouse liver transplantation","volume":"14","author":"Kadono","year":"2023","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2024.155776_bib0005","first-page":"1","article-title":"Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease","volume":"44","author":"Kong","year":"2024","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.phymed.2024.155776_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107266","article-title":"STAT6 up-regulation amplifies M2 macrophage anti-inflammatory capacity through mesenchymal stem cells","volume":"91","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0043","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic Adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2024.155776_bib0031","first-page":"11184","article-title":"Inhibiting microRNA-200a-3p attenuates pyroptosis via targeting the SIRT1\/NF-kappaB\/NLRP3 pathway in H(2)O(2)-induced HAEC","volume":"15","author":"Liu","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.phymed.2024.155776_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103114","article-title":"Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease","volume":"71","author":"Miao","year":"2024","journal-title":"Redox. Biol."},{"key":"10.1016\/j.phymed.2024.155776_bib0014","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155776_bib0032","article-title":"The promotion of fatty acid beta-oxidation by hesperidin via activating SIRT1\/PGC1alpha to improve NAFLD induced by a high-fat diet","author":"Nie","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.phymed.2024.155776_bib0037","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.ircmb.2022.04.006","article-title":"Macrophages as key regulators of liver health and disease","volume":"368","author":"Papachristoforou","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.phymed.2024.155776_bib0006","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2014.12.019","article-title":"Treatment in vitro with PPARalpha and PPARgamma ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice","volume":"1852","author":"Penas","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2024.155776_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155111","article-title":"Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy","volume":"121","author":"Qiu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155776_bib0040","first-page":"830","article-title":"SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice","volume":"21","author":"Ren","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phymed.2024.155776_bib0033","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ptr.7686","article-title":"Narirutin exerts anti-inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages","volume":"37","author":"Ri","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2024.155776_bib0002","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155776_bib0038","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155776_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s00005-020-00576-4","article-title":"Current status of M1 and M2 macrophages pathway as drug targets for inflammatory bowel disease","volume":"68","author":"Seyedizade","year":"2020","journal-title":"Arch. Immunol. Ther. Ex."},{"key":"10.1016\/j.phymed.2024.155776_bib0025","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1248\/bpb.b18-00984","article-title":"Cranberry attenuates progression of non-alcoholic fatty liver disease induced by high-fat diet in mice","volume":"42","author":"Shimizu","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2024.155776_bib0046","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155776_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101781","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"69","author":"Vasudevan","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.phymed.2024.155776_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao4617","article-title":"IRE1alpha prevents hepatic steatosis by processing and promoting the degradation of select microRNAs","volume":"11","author":"Wang","year":"2018","journal-title":"Sci. Signal"},{"key":"10.1016\/j.phymed.2024.155776_bib0034","article-title":"Alisol A Alleviates Arterial Plaque by Activating AMPK\/SIRT1 Signaling Pathway in apoE-Deficient Mice","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155776_bib0042","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41387-020-00130-3","article-title":"Neohesperidin enhances PGC-1alpha-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice","volume":"10","author":"Wang","year":"2020","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.phymed.2024.155776_bib0021","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2020.11.009","article-title":"NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice","volume":"534","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155776_bib0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000452492","article-title":"Neohesperidin exerts lipid-regulating effects in vitro and in vivo via fibroblast growth factor 21 and AMP-activated protein Kinase\/Sirtuin Type 1\/Peroxisome proliferator-activated receptor gamma Coactivator 1alpha signaling axis","volume":"100","author":"Wu","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.phymed.2024.155776_bib0011","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.bbrc.2018.07.090","article-title":"Saxagliptin regulates M1\/M2 macrophage polarization via CaMKKbeta\/AMPK pathway to attenuate NAFLD","volume":"503","author":"Yang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155776_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841732","article-title":"Pyroptosis and its role in autoimmune disease: a potential therapeutic target","volume":"13","author":"You","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2024.155776_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155776_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115828","article-title":"Quality evaluation of Pterocephali Herba through simultaneously quantifying 18 bioactive components by UPLC-TQ-MS\/MS analysis","volume":"238","author":"Zeng","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2024.155776_bib0044","article-title":"Macrophage metabolism in nonalcoholic fatty liver disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2024.155776_bib0015","article-title":"The role of autophagy and pyroptosis in liver disorders","volume":"23","author":"Zhao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155776_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166810","article-title":"FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression","volume":"1869","author":"Zhou","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T18:34:32Z","timestamp":1718994872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":47,"alternative-id":["S0944711324004343"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155776","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155776"}}